Your browser doesn't support javascript.
loading
Identification of complex genomic rearrangements in cancers using CouGaR.
Dzamba, Misko; Ramani, Arun K; Buczkowicz, Pawel; Jiang, Yue; Yu, Man; Hawkins, Cynthia; Brudno, Michael.
Afiliação
  • Dzamba M; Department of Computer Science, University of Toronto, Toronto, Ontario, M5S 3G4, Canada.
  • Ramani AK; Centre for Computational Medicine, The Hospital for Sick Children, Toronto, Ontario, M5G 0A4, Canada.
  • Buczkowicz P; Division of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1E8, Canada.
  • Jiang Y; Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, M5G 0A4, Canada.
  • Yu M; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, M5G 1E8, Canada.
  • Hawkins C; Centre for Computational Medicine, The Hospital for Sick Children, Toronto, Ontario, M5G 0A4, Canada.
  • Brudno M; Division of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1E8, Canada.
Genome Res ; 27(1): 107-117, 2017 01.
Article em En | MEDLINE | ID: mdl-27986820
The genomic alterations associated with cancers are numerous and varied, involving both isolated and large-scale complex genomic rearrangements (CGRs). Although the underlying mechanisms are not well understood, CGRs have been implicated in tumorigenesis. Here, we introduce CouGaR, a novel method for characterizing the genomic structure of amplified CGRs, leveraging both depth of coverage (DOC) and discordant pair-end mapping techniques. We applied our method to whole-genome sequencing (WGS) samples from The Cancer Genome Atlas and identify amplified CGRs in at least 5.2% (10+ copies) to 17.8% (6+ copies) of the samples. Furthermore, ∼95% of these amplified CGRs contain genes previously implicated in tumorigenesis, indicating the importance and widespread occurrence of CGRs in cancers. Additionally, CouGaR identified the occurrence of 'chromoplexy' in nearly 63% of all prostate cancer samples and 30% of all bladder cancer samples. To further validate the accuracy of our method, we experimentally tested 17 predicted fusions in two pediatric glioma samples and validated 15 of these (88%) with precise resolution of the breakpoints via qPCR experiments and Sanger sequencing, with nearly perfect copy count concordance. Additionally, to further help display and understand the structure of CGRs, we have implemented CouGaR-viz, a generic stand-alone tool for visualization of the copy count of regions, breakpoints, and relevant genes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Genoma Humano / Carcinogênese / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Genome Res Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Genoma Humano / Carcinogênese / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Genome Res Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá